MURPHY CANYON ACQUISITION Stock Price, News & Analysis

MURFU NASDAQ

Company Description

MURPHY CANYON ACQUISITION (NASDAQ: MURFU) is a publicly traded company.

MURFU stock has declined 100.0% over the past year.

This page provides a comprehensive overview of MURFU stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-100%

Performance 1 year

$0.0

Market Cap

14.0M

Shares outstanding

MURPHY CANYON ACQUISITION (MURFU) stock. Over the past 12 months, the stock has lost 100.0%.

Latest News

View All

September 20, 2023

-10.37%

Murphy Canyon Acquisition Corp. Announces Stockholder Approval of the Proposed Combination with Conduit Pharmaceuticals Limited

acquisition

February 7, 2022

+0.40%

Murphy Canyon Acquisition Corp. Announces Closing of $132.25 Million Initial Public Offering

IPO offering acquisition

February 4, 2022

+0.20%

Murphy Canyon Acquisition Corp. Announces Full Exercise of Underwriters' Over-Allotment Option in Public Offering

offering acquisition

February 2, 2022

0.00%

Murphy Canyon Acquisition Corp. Announces Pricing of $115 Million Initial Public Offering

IPO offering acquisition

MURPHY CANYON ACQUISITION has 4 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition, IPO, offering. View all MURFU news →

SEC Filings

View All

No SEC filings available for MURFU.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months